How this biotech company is bringing software to big pharma - Technical.ly Baltimore

Business

Jul. 11, 2016 9:36 am

How this biotech company is bringing software to big pharma

SilcsBio does drug discovery via software. The company just got a $1.2 million award from the federal government to ramp up research efforts.

Computer-aided drug discovery is a growing field.

(Photo courtesy of Sinai Hospital BioIncubator)

Since completing a 2013 licensing deal with UM Ventures for technology that brings computers into the process of pharmaceutical drug discovery, SilcsBio has been growing its product offerings and sales.

Now, the company is getting a boost from the federal government. The company was awarded a Phase II Small Business Innovation Research (SBIR) award for $1.2 million, CEO Ken Malone said via email.

The funding from the National Institutes of Health will provide capital for the company to improve its capabilities in Computer-Aided Drug Design (CADD). The company’s existing products contain algorithms that map proteins, allowing specialists to test how they will perform with potential drugs that pharmaceutical companies are developing.

“This funding will allow us to improve upon our already best in class accuracy and extend its use into protein-protein interactions,” Dr. Alex MacKerell, the company’s chief science officer, said in a statement.

The company showed growth leading up to this point. Malone reported sales to several pharmaceutical companies, and four employees who were once part-time are now full-time, with a half-dozen more part-timers now on board.

“We’ve found that sales cycles to large pharma companies are years not months as they perform extensive trials,” Malone wrote. “So we are just now seeing the benefits of our work from two years ago and the great news is that we are adding new customers and getting repeat business because all the trials have worked perfect.”

The company also changed office locations at the beginning of 2016, moving from the University of Maryland BioPark to downtown’s Spark Baltimore. Malone said the recently opened startup space above Power Plant Live! “eliminates our concerns about physical infrastructure.”

“We can spend all our time focusing on our team and customers,” he said.

Companies: SilcsBio
People: Ken Malone
-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here

Advertisement

Building a data acquisition system? Don’t make this mistake

Why Paragon Bioservices’ $1.2B acquisition deal matters to Baltimore

The acquisition deal for Columbia-based Osiris Therapeutics is now complete

SPONSORED

Baltimore

Building a data acquisition system? Don’t make this mistake

Baltimore, MD

Whitebox

Javascript Developer

Apply Now
Baltimore

14 West

Reporting Analyst

Apply Now
Baltimore

14 West

Project Analyst

Apply Now

Paragon Bioservices expands, plans hires with new manufacturing facility

5 Qs with Emily English, CEO of Gemstone Biotherapeutics

Columbia-based Osiris Therapeutics to be acquired in $660M deal

SPONSORED

Baltimore

How SmartLogic accelerated these startups’ product growth trajectories

Baltimore

14 West

Senior Java Software Engineer

Apply Now
Baltimore

14 West

Project Specialist

Apply Now
Baltimore

14 West

Senior Business Analyst (Accounting)

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!